1. Home
  2. GME vs PRAX Comparison

GME vs PRAX Comparison

Compare GME & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameStop Corporation

GME

GameStop Corporation

HOLD

Current Price

$25.06

Market Cap

10.3B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$323.72

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GME
PRAX
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electronics Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
9.6B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
GME
PRAX
Price
$25.06
$323.72
Analyst Decision
Sell
Strong Buy
Analyst Count
1
15
Target Price
$13.50
$572.13
AVG Volume (30 Days)
6.4M
316.0K
Earning Date
06-09-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
133.33
N/A
EPS
0.77
N/A
Revenue
$3,629,900,000.00
N/A
Revenue This Year
$18.98
N/A
Revenue Next Year
N/A
$7,758.26
P/E Ratio
$31.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.94
$34.89
52 Week High
$35.81
$354.87

Technical Indicators

Market Signals
Indicator
GME
PRAX
Relative Strength Index (RSI) 56.04 49.69
Support Level $22.28 $282.49
Resistance Level $25.97 $327.65
Average True Range (ATR) 0.87 18.73
MACD 0.04 -1.64
Stochastic Oscillator 67.35 23.11

Price Performance

Historical Comparison
GME
PRAX

About GME GameStop Corporation

GameStop Corp offers games, collectibles, and entertainment products through its stores and ecommerce platforms. Its products include Hardware and accessories offering new and pre-owned gaming platforms from the console manufacturers, Software offering new and pre-owned gaming software for current and certain prior generation consoles and sell a wide range of in-game digital currency, digital downloadable content and full-game downloads, and Collectibles consist of apparel, toys, trading cards, gadgets and other retail products for pop culture and technology enthusiasts and collectibles related services, such as submission services for the authentication and grading of trading cards. The company operates its business in three geographic segments: the United States, Australia, and Europe.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: